FDA approves Botox Cosmetic for neck wrinkles ABBV.US expands its aesthetic portfolio
1min read The U.S. Food and Drug Administration recently approved Botox Cosmetic's fourth indication, marking the first time the anti-wrinkle therapy has been expanded beyond the face. The new approval will allow adults to use Botox Cosmetic to temporarily improve the appearance of moderate to severe vertical bands (platysma bands) between the jawline and neck.Botox Cosmetic, which is marketed by AbbVie (ABBV.US), is the first and only product to receive four aesthetic indications, and has previously been used to improve frown lines, forehead lines and crow's feet. AbbVie acquired Allergan in 2020 for $63 billion, expanding its product line in the aesthetics space.The approval of Botox Cosmetic was based on data from a Phase 3 clinical trial that showed the therapy significantly improved the appearance of platysma bands compared to placebo, making it the first product in its class to be expanded beyond the face.
